← Back to guidelines
Sports Medicine6 papers

Progressive angina

Last edited:

Overview

Progressive angina in athletes, particularly those engaged in ultraendurance activities, represents a complex interplay of physiological stress, cumulative fatigue, and cardiovascular strain. This condition is characterized by a gradual worsening of angina symptoms that may not be fully explained by traditional atherosclerotic coronary artery disease alone. The evidence primarily stems from case studies and specific athlete profiles, highlighting the unique challenges faced by individuals undertaking extreme endurance training regimens. Understanding the pathophysiology, clinical presentation, management strategies, and potential complications is crucial for clinicians managing such athletes to prevent long-term cardiovascular risks.

Pathophysiology

The pathophysiology of progressive angina in ultraendurance athletes involves multifaceted physiological stressors that can lead to significant cardiovascular strain. A notable case study involving an ultraendurance athlete completing 100 long-distance triathlons over 100 days revealed substantial nonlinear changes in resting heart rate, heart-rate variability (HRV), and sleep parameters [PMID:36898387]. These alterations suggest that extreme endurance activities impose considerable physiological stress on the cardiovascular system, potentially leading to myocardial ischemia and angina. Reduced HRV, often indicative of autonomic dysfunction, can impair the heart's ability to adapt to varying metabolic demands, thereby increasing the risk of ischemia during prolonged exertion [PMID:36898387].

Moreover, the cumulative effects of repeated intense training sessions can exacerbate subclinical myocardial injury, contributing to progressive angina. The observed reductions in HRV and sleep disturbances highlight the cumulative fatigue and stress experienced by these athletes, which may reflect underlying subclinical myocardial changes. These physiological markers are not only indicative of acute stress but also suggest a chronic adaptation process that can strain the coronary microvasculature, making it more susceptible to ischemia under stress [PMID:36898387]. In clinical practice, monitoring these biomarkers can provide early insights into cardiovascular health deterioration in athletes.

Clinical Presentation

The clinical presentation of progressive angina in ultraendurance athletes often includes both cardiovascular and cognitive symptoms, reflecting the multifaceted impact of prolonged physical stress. Athletes frequently exhibit compromised simple reaction times following intense events, such as ultraendurance swims, which may indicate cognitive fatigue and diminished neurocognitive function [PMID:41106848]. This cognitive impairment can affect decision-making and performance during subsequent training sessions or competitions, underscoring the importance of comprehensive recovery strategies.

Throughout rigorous training regimens, athletes may also experience recurrent episodes of angina that progressively worsen despite adequate rest periods. These episodes are often accompanied by subjective symptoms such as chest pain, dyspnea, and palpitations, particularly during or immediately following intense training sessions [PMID:36898387]. Additionally, physiological markers like reduced HRV and altered sleep metrics serve as clinical indicators of cumulative fatigue and stress. For instance, in a case study of an ex-Olympic rower competing in the Marathon des Sables, mean heart rates consistently remained elevated at 66.1 ± 13.4% of maximum capacity, alongside fluctuating core body temperatures ranging from 36.63°C to 39.65°C [PMID:24445543]. Such fluctuations in core temperature can exacerbate cardiovascular strain and increase the risk of heat-related complications, further complicating the clinical picture.

Diagnosis

Diagnosing progressive angina in ultraendurance athletes requires a multifaceted approach that integrates clinical symptoms with objective physiological assessments. Traditional diagnostic tools such as electrocardiograms (ECGs), echocardiography, and stress testing remain foundational but may need to be complemented by advanced monitoring techniques. Specifically, continuous monitoring of heart-rate variability (HRV) and sleep quality can provide valuable insights into the athlete's cumulative stress levels and recovery status [PMID:36898387]. Elevated resting heart rates, decreased HRV, and disrupted sleep patterns are indicative of underlying cardiovascular strain and should prompt further investigation.

Imaging modalities such as coronary CT angiography or MRI can help rule out structural coronary artery disease, which is crucial given that progressive angina in these athletes may not always be due to atherosclerotic lesions. Instead, microvascular dysfunction or transient myocardial ischemia might play significant roles. Additionally, biomarkers like troponin levels, though typically elevated in acute myocardial infarction, can sometimes show subtle changes in chronic stress scenarios, warranting their periodic assessment [PMID:36898387]. Clinicians should also consider environmental factors, such as extreme temperatures, which can exacerbate symptoms and complicate diagnosis, as seen in the Marathon des Sables case where core body temperatures reached critical levels [PMID:24445543].

Management

Effective management of progressive angina in ultraendurance athletes involves a holistic approach that addresses both physiological and psychological aspects of recovery and performance. Nutritional strategies are paramount, emphasizing intentional replenishment of macronutrients and micronutrients to sustain cardiometabolic fitness during prolonged, challenging conditions [PMID:41106848]. Ensuring adequate hydration, electrolyte balance, and caloric intake is crucial, particularly in high-elevation or extreme environmental conditions where metabolic demands are heightened.

Regular monitoring of physiological biomarkers, including HRV and sleep quality, is essential for tailoring training programs and recovery protocols [PMID:36898387]. This proactive approach allows for timely adjustments to training intensity and volume, mitigating the risk of exacerbating cardiovascular strain. For instance, implementing a structured taper phase before major events can help reduce cumulative fatigue. Additionally, incorporating specific acclimatization protocols, such as the 7-day heat acclimation regimen observed in the Marathon des Sables participant, can mitigate physiological strain and improve thermoregulation [PMID:24445543].

Psychological support is another critical component, especially for athletes facing unique mental challenges. Female ultraendurance athletes, in particular, may require specialized psychological interventions to address the unique pressures and stressors they encounter [PMID:41106848]. Cognitive-behavioral therapy, stress management techniques, and peer support groups can enhance mental resilience and overall well-being, contributing to better physical recovery and performance outcomes.

Key Recommendations

  • Regular Monitoring: Implement routine assessments of HRV, sleep quality, and core body temperature to detect early signs of cardiovascular strain.
  • Nutritional Support: Develop personalized nutrition plans focusing on balanced macronutrient intake, hydration, and electrolyte balance.
  • Training Adaptation: Adjust training intensity and volume based on physiological markers to prevent cumulative fatigue and ischemia.
  • Acclimatization Protocols: Incorporate acclimatization strategies, such as heat acclimation, to enhance physiological resilience.
  • Psychological Support: Provide specialized psychological support, particularly for female athletes, to address mental health and stress management.
  • Environmental Considerations: Account for environmental factors like temperature extremes when designing training and competition schedules.
  • By integrating these recommendations, clinicians can better manage the complex needs of ultraendurance athletes, reducing the risk of progressive angina and promoting long-term cardiovascular health.

    References

    1 Paris HL, Ganey AE, Goll AF, Kroeze AW, Thomas TM, Webster FE et al.. Breathless but buoyed: a female athlete's record-breaking ultraendurance swim 1,900 m above sea level. Journal of applied physiology (Bethesda, Md. : 1985) 2025. link 2 Anderson T, van Mourik RA, Martin KJ, Eijsvogels TMH, Longoria KA. 100 Long-Distance Triathlons in 100 Days: A Case Study on Ultraendurance, Biomarkers, and Physiological Outcomes. International journal of sports physiology and performance 2023. link 3 Williams N, Wickes SJ, Gilmour K, Barker N, Scott JP. Preparation for and physiological responses to competing in the Marathon des Sables: a case report. The Journal of sports medicine and physical fitness 2014. link

    3 papers cited of 5 indexed.

    Original source

    1. [1]
      Breathless but buoyed: a female athlete's record-breaking ultraendurance swim 1,900 m above sea level.Paris HL, Ganey AE, Goll AF, Kroeze AW, Thomas TM, Webster FE et al. Journal of applied physiology (Bethesda, Md. : 1985) (2025)
    2. [2]
      100 Long-Distance Triathlons in 100 Days: A Case Study on Ultraendurance, Biomarkers, and Physiological Outcomes.Anderson T, van Mourik RA, Martin KJ, Eijsvogels TMH, Longoria KA International journal of sports physiology and performance (2023)
    3. [3]
      Preparation for and physiological responses to competing in the Marathon des Sables: a case report.Williams N, Wickes SJ, Gilmour K, Barker N, Scott JP The Journal of sports medicine and physical fitness (2014)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG